Exyn Technologies (EXYN) notifies SEC of late 10-Q for quarter ended Mar 31, 2026
Filing Impact
Filing Sentiment
Form Type
NT 10-Q
Rhea-AI Filing Summary
Exyn Technologies, Inc. filed a Form 12b-25 notifying the SEC that its Quarterly Report on Form 10-Q for the period ended March 31, 2026 will be filed late. The company says this is its first periodic report following effectiveness of its Form S-1 and expects to file the Form 10-Q no later than the fifth calendar day following the prescribed due date.
The delay is attributed to the additional time needed to finalize interim financial information and complete related review procedures. Contact: Pedro Ricardo Sotelo, CFO.
Positive
- None.
Negative
- None.
Key Figures
Reporting period: March 31, 2026
Cure period: fifth calendar day following the prescribed due date
Notification date: June 30, 2026
+1 more
4 metrics
Reporting period
March 31, 2026
Quarter ended
Cure period
fifth calendar day following the prescribed due date
Rule 12b-25(b) filing extension for quarterly reports
Notification date
June 30, 2026
Date signature executed by CFO
Contact phone
(917) 806-1345
Pedro Ricardo Sotelo, Chief Financial Officer
Key Terms
Rule 12b-25, Form S-1, interim review procedures
3 terms
Rule 12b-25 regulatory
"The Company expects to file the Form 10-Q no later than the fifth calendar day following the prescribed due date"
Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.
Form S-1 regulatory
"following the effectiveness of the registration statement on Form S-1 relating to the Company's initial public offering"
A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.
interim review procedures financial
"finalizing the interim financial information and completing the related interim review procedures"
FAQ
Why did EXYN file a Form 12b-25 for the quarter ended March 31, 2026?
The company states additional time is needed to finalize interim financial information and complete related interim review procedures. This delay follows the effectiveness of its Form S-1 and is described as requiring unreasonable effort or expense to eliminate.
When does Exyn expect to file the delayed Form 10-Q (EXYN)?
Exyn expects to file the Form 10-Q no later than the fifth calendar day following the prescribed due date, consistent with Rule 12b-25(b). The filing identifies the quarter ended March 31, 2026 as the period covered.
Is this the first periodic report required from EXYN after its IPO?
Yes. The notice states this is the company's first periodic report required under the Exchange Act after the Form S-1 registration statement became effective, and it had no periodic-reporting obligation in the prior 12 months.
Who can investors contact about the late filing for EXYN?
The Form 12b-25 lists Pedro Ricardo Sotelo, Chief Financial Officer, with phone number (917) 806-1345 as the contact for questions regarding the notification and the delayed Form 10-Q.
Will the delayed filing indicate significant changes in results for EXYN?
The company indicated No to anticipated significant changes in results of operations versus the corresponding prior-year period. It did not attach quantitative changes or an explanatory schedule in this notification.